$BEEP Cashflow Statement | Understand Stock

$BEEP

$2.53 -$0.02 (0.78%) Close

$BEEP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 10 months to Dec 31, 2021
Cash flows from operating activities:
Net Loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares
Income from investments held in Trust Account
Depreciation and amortization expense
Amortization of loan costs and discounts
Loss on extinguishment of debt
Notes Payable, Other Payables
SBA CARES Act Paycheck Protection Program
Total loss on extinguishment of debt
Gain on settlement of liability
Loss on interest rate hedge
Loss (gain) on sale of real estate
Equity-based payment
Impairment
Issuance of Preferred Series 2 Stock
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease)

Changes in operating assets and liabilities
Prepaid expenses
Accounts payable
Accrued expenses
Due to/from related parties
Accounts payable and accrued expenses
Indemnification liability
Deferred offering costs
Deposits
Other assets
Deferred revenue
Accounts receivable, net
Net cash provided by (used in) operating activities

Cash flows from investing activities:
Cash deposited in Trust Account
Capital expenditures
Capitalized technology
Purchase of investment in real estate
Proceeds from sale of investment in real estate
Insurance reimbursement for capital expenditures
Proceeds from note receivable
Proceeds on sale of investment in real estate
Net cash provided by investing activities

Cash flows from financing activities:
Repayment of note payable to related party
Proceeds from note payable to related party
Proceeds received from private placement
Proceeds received from initial public offering, gross
Offering costs paid
Proceeds from Line of Credit
Proceeds from notes payable
Proceeds from reverse recap, net of payment of equity issuance costs
Payment of transaction costs for reverse recapitalization
Payment on interest rate cap
Payments on notes payable
Payments on Revolving Credit Facility
Payments on Line of Credit
Distributions to non-controlling interest holders
Purchase of minority interest in subsidiary
Loan fees
Share repurchase plan
Shares repurchased for vesting of employee awards
Preferred redemption payments
Preferred distribution payments
Net cash used in financing activities
Net change in cash and cash equivalents and restricted cash
Cash - beginning of the period
Cash - end of the period
Offering costs included in accrued expenses
Deferred underwriting commissions in connection with the initial public offering
Extinguishment of deferred underwriting commissions allocated to Public Shares
Cash and cash equivalents and restricted cash, beginning of period
Cash and cash equivalents at end of period
Restricted cash at end of period
Cash and cash equivalents and restricted cash, end of period

Supplemental disclosures of cash flow information:
Interest Paid
Non-cash investing and financing activities:
Dividends declared not yet paid
Distributions paid in common stock
Distributions declared not yet paid
Preferred distributions paid in common stock
Accrued preferred distributions paid in common stock
Right of use asset and lease liability
Note receivable related to disposition of property
Requested preferred redemptions not yet paid
Stock issued
Share Issued as Loan Fees
Share Issued in Exchange for Accrued Compensation
Total stock issued
Shares issued or to be issued in exchange for compensation (in shares)
Series 2 Preferred Stock dividend paid-in-kind
Series 2 Preferred Stock
Total series 2 Preferred Stock dividend paid-in-kind
Accrued capital expenditures
Reconciliation of cash and cash equivalents and restricted cash:
Cash and cash equivalents at beginning of period
Restricted cash at beginning of period

Comments